The effects of sequential combined oral 17&bgr;-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Menopause

• Publication date

  2001-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00042192-200101000-00006PMID 11201511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma cholesterol esterification and transfer, the menopause, and hormone replacement therapy in women.

  1999cited by this paper
• Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.

  1999cited by this paper
• Effect of percutaneous androgen replacement therapy on body composition and body weight in postmenopausal women.

  1998cited by this paper
• The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women.

  1998cited by this paper
• Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women.

  1997cited by this paper
• Relative influence of age and menopause on total and regional body composition changes in postmenopausal women.

  1996cited by this paper
• Hormone replacement therapy and cardiovascular disease: the human model.

  1996cited by this paper
• Clinical and laboratory characteristics of human granulocytic ehrlichiosis.

  1996cited by this paper
• DEXA supports the use of BMI as a measure of fatness in young girls.

  1996cited by this paper
• A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.

  1995cited by this paper
• Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

  1995cited by this paper
• The effects of increasing doses of enalapril on insulin sensitivity in normotensive non-insulin dependent diabetic subjects.

  1995cited by this paper
• Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry.

  1995cited by this paper
• The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass.

  1995cited by this paper
• Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women

  1994cited by this paper
• A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin.

  1993cited by this paper
• Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.

  1993cited by this paper
• Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women.

  1992cited by this paper
• Sex- and menopause-associated changes in body-fat distribution.

  1992cited by this paper
• Effects of Low Doses of Transdermal 17β-Estradiol on Carbohydrate Metabolism in Postmenopausal Women

  1992cited by this paper
• Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort.

  1991cited by this paper
• Ischemic heart disease risk in postmenopausal women. Effects of estrogen use on glucose and insulin levels.

  1990cited by this paper
• The Epidemiology of Cardiovascular Disease in Postmenopausal Women

  1990cited by this paper
• Increased risk of atherosclerosis in women after the menopause.

  1989cited by this paper
• Carbohydrate metabolism during hormonal substitution therapy.

  1989cited by this paper
• Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

  1987cited by this paper
• Effects of natural oestrogen/progestogen substitution therapy on carbohydrate and lipid metabolism in post-menopausal women.

  1986cited by this paper
• A prospective study of postmenopausal estrogen therapy and coronary heart disease.

  1985cited by this paper
• Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

  1984cited by this paper
• A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clamping

  1984cited by this paper
• Mechanisms of Insulin Resistance Following Injury

  1982cited by this paper
• Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man.

  1981cited by this paper
• Glucose clamp technique: a method for quantifying insulin secretion and resistance.

  1979cited by this paper
• A model of the kinetics of insulin in man.

  1974cited by this paper
• The effect of estrogens on carbohydrate metabolism: glucose, insulin, and growth hormone studies on one hundred and seventy-one women ingesting Premarin, mestranol, and ethinyl estradiol for six months.

  1972cited by this paper
• Relative effects of pregnancy, estradiol, and progesterone on plasma insulin and pancreatic islet insulin secretion.

  1971cited by this paper
• Effects of estrogen on glucose tolerance.

  1966cited by this paper

• Hormone therapy and insulin resistance in non-diabetic postmenopausal women: a systematic review and meta-analysis

  2025cites this paper
• Effects of Transdermal 17β-Estradiol + Norethisterone Acetate on Cardiovascular Disease Risk Factors in Postmenopausal Women: A Meta-Analysis of Data From Randomized, Controlled Trials.

  2023cites this paper
• The effect of 17beta-estradiol plus norethisterone acetate on anthropometric indices: A systematic review and meta-analysis of randomized controlled trials.

  2023cites this paper
• The influence of 17β-estradiol plus norethisterone acetate treatment on markers of glucose and insulin metabolism in women: a systematic review and meta-analysis of randomized controlled trials

  2023cites this paper
• The effect of 17β-estradiol plus norethisterone acetate on blood pressure and inflammation markers: A meta-analysis of randomized controlled trials.

  2023cites this paper
• Effect of menopausal hormone therapy on components of the metabolic syndrome

  2017cites this paper
• Visceral fat accumulation: is it caused by estrogen deficiency?

  2015cites this paper
• Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study

  2015cites this paper
• Body composition and bone mineral density after ovarian hormone suppression with or without estradiol treatment

  2015cites this paper
• C Body composition and bone mineral density after ovarian hormone

  2015cites this paper
• THE EFFECTS OF LOW DOSE HORMONE THERAPY ON SERUM LIPID PROFILE, GLISEMIC CONTROL, THYROID HORMONES AND ANDROGEN LEVELS IN POSTMENOPAUSAL WOMEN

  2011cites this paper
• DÜfiÜK DOZ HORMON TEDAV‹S‹N‹N POSTMENOPOZAL KADINLARDA L‹P‹D PROF‹L‹, GL‹SEM‹K KONTROL, T‹RO‹D HORMONLARI VE ANDROJENLER ÜZER‹NE ETK‹LER‹

  2011cites this paper
• Body fat distribution is associated with lumbar spine bone density independently of body weight in postmenopausal women.

  2011cites this paper
• Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle.

  2010cites this paper
• Insulin secretion and clearance after subacute estradiol administration in postmenopausal women.

  2008cites this paper
• Hormone replacement therapy and diabetes

  2008cites this paper
• Effects of postmenopausal hormone replacement therapy on body fat composition

  2007cites this paper
• Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity.

  2007cites this paper
• Effects of standard and low dose 17beta-estradiol plus norethisterone acetate on body composition and leptin in postmenopausal women at risk of body mass index and waist girth related cardiovascular and metabolic disease.

  2007cites this paper
• Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal.

  2007cites this paper
• STUDIES IN SPORT, PHYSICAL EDUCATION AND HEALTH 117

  2006cites this paper
• Effects of oral continuous 17β-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition

  2006cites this paper
• Meta‐analysis: effect of hormone‐replacement therapy on components of the metabolic syndrome in postmenopausal women

  2006cites this paper
• Association of serum proinsulin with hormone replacement therapy in nondiabetic older women: the Rancho Bernardo Study.

  2006cites this paper
• The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial.

  2005cites this paper
• Evaluation of the effects of various gestagens on insulin sensitivity, using homeostatic model assessment, in postmenopausal women on hormone replacement therapy

  2005cites this paper
• Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.

  2005cites this paper
• Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women’s Health Initiative Hormone Trial

  2004cites this paper
• HRT does not improve urinary albumin excretion in postmenopausal diabetic women.

  2003cites this paper
• Body composition and muscle performance during menopause and hormone replacement therapy

  2003cites this paper
• Usual dietary isoflavone intake and body composition in postmenopausal women

  2003cites this paper
• Relative contribution of aging and menopause to changes in lean and fat mass in segmental regions.

  2002cites this paper